Abdominal Pain News and Research

RSS

Abdominal pain is traditionally described by its chronicity (acute or chronic), its progression over time, its nature (sharp, dull, colicky), its distribution (by various methods, such as abdominal quadrant (left upper quadrant, left lower quadrant, right upper quadrant, right lower quadrant) or other methods that divide the abdomen into nine sections), and by characterization of the factors that make it worse, or alleviate it.

FDA completes review of FluMist

MedImmune, Inc. has announced that the U.S. Food and Drug Administration (FDA) has stated the agency has completed its review of all submissions made related to the supplemental biologics license application (sBLA) to extend the age indication of FluMist (Influenza Virus Vaccine Live, Intranasal).

28 May 2007

New weapons in the fight against food poisoning

University of Nottingham experts have joined forces with Canadian biotech company GangaGen Life Sciences Inc to develop new weapons in the fight against food poisoning.

28 May 2007

New smart pill helps diagnose stomach problems

People with the chronic stomach condition known as gastroparesis, or slow stomach emptying, live in fear that eating will cause an episode of nausea, vomiting and abdominal pain.

24 May 2007

New weapons in the fight against food poisoning

University of Nottingham experts have joined forces with Canadian biotech company GangaGen Life Sciences Inc to develop new weapons in the fight against food poisoning.

24 May 2007

Daytrana provides significant effectiveness in both boys and girls with ADHD

Shire plc has announced that DAYTRANA (methylphenidate transdermal system), its Attention Deficit Hyperactivity Disorder (ADHD) patch, had significant efficacy in reducing the symptoms of ADHD in both male and female children aged 6 to 12 years, according to clinical trial results reported at the American Psychiatric Association (APA) annual meeting in San Diego.

24 May 2007

Lubiprostone may improve symptom relief rates in adults with irritable bowel syndrome with constipation

A new study demonstrated that the active ingredient in AMITIZA (lubiprostone), given 8 mcg twice a day, may improve symptom relief rates in adults with irritable bowel syndrome with constipation (IBS-C).

22 May 2007

Lubiprostone may improve symptom relief rates in adults with irritable bowel syndrome

22 May 2007

Capsule endoscopy effective in diagnosing gastrointestinal bleeding and small bowel Crohn's disease in children

The technology has been used successfully at Thomas Jefferson University Hospital for more than five years to diagnose unexplained abdominal bleeding in adults.

22 May 2007

Ulcerative colitis disruptive in relationships

Nearly three out of four ulcerative colitis (UC) sufferers (73 percent) responding to a new nationwide survey say not feeling well has become a normal part of life.

18 May 2007

Minimally invasive treatment of chronic mesenteric ischemia

Using catheter techniques perfected in the arteries of the heart, interventional cardiologists are successfully treating chronic mesenteric ischemia, a condition akin to intestinal angina.

17 May 2007

Bisphosphonates for osteoporosis treatment in women

A class of drugs called bisphosphonates has become the new mainstay treatment for postmenopausal women diagnosed with osteoporosis in the post-hormone-replacement era.

10 May 2007

Low-dose MDCT of the abdomen and pelvis reduces hospital stay in patients with acute nonspecific abdominal pain

Extremely low-dose MDCT of the abdomen and pelvis is useful in providing needed diagnostic information and reducing hospital stay in patients with acute nonspecific abdominal pain, according to a new study by researchers from the Emory University School of Medicine in Atlanta, GA, and Massachusetts General Hospital in Boston, MA.

9 May 2007

FluMist may help reduce the burden of seasonal influenza

MedImmune, Inc. has announced research results showing that use of FluMist(R) (Influenza Virus Vaccine Live, Intranasal) in daycare and school settings may help reduce the burden of seasonal influenza.

9 May 2007

Extremely low-dose MDCT useful for reducing hospital stay for patients with acute abdominal pain

8 May 2007

Adalimumab shows potential for Crohn's disease

A study led by Mayo Clinic found that adalimumab (HUMIRA) is an effective treatment for adults with Crohn's disease who do not respond to infliximab (REMICADE) therapy.

2 May 2007

Virtual colonoscopy most cost-effective colon cancer screening test

A new study says targeting smaller (5 mm) lesions does little to significantly reduce the incidence of colorectal cancer (CRC) and, in fact, results in extremely high financial costs and a large proportion of adverse events.

24 Apr 2007

Discovery of important clue to the susceptibility of individuals to Crohn's disease

Crohn's disease is a chronic relapsing inflammatory disorder of the intestinal tract that affects an estimated 0.15% of people in the developed world. Common symptoms include abdominal pain and diarrhea, but the disorder is often associated with debilitating clinical complications.

21 Apr 2007

Schering-Plough announces ZETIA spproved in Japan

Schering-Plough Corporation has announced that Schering-Plough K.K., the company's country operation in Japan, has received marketing approval for ZETIA (ezetimibe), a novel cholesterol-lowering agent that inhibits the absorption of cholesterol in the intestine.

20 Apr 2007

Researchers identify key gene that may be a marker of breast cancer metastasis

Despite the fact that they both infect the liver, the hepatitis A and hepatitis C viruses actually have very little in common.

19 Apr 2007

Researchers find hepatitis A and hepatitis C attack same protein to block immune defenses

Despite the fact that they both infect the liver, the hepatitis A and hepatitis C viruses actually have very little in common.

19 Apr 2007

Abdominal Pain News and Research

Further Reading

FDA completes review of FluMist

New weapons in the fight against food poisoning

New smart pill helps diagnose stomach problems

New weapons in the fight against food poisoning

Daytrana provides significant effectiveness in both boys and girls with ADHD

Lubiprostone may improve symptom relief rates in adults with irritable bowel syndrome with constipation

Lubiprostone may improve symptom relief rates in adults with irritable bowel syndrome

Capsule endoscopy effective in diagnosing gastrointestinal bleeding and small bowel Crohn's disease in children

Ulcerative colitis disruptive in relationships

Minimally invasive treatment of chronic mesenteric ischemia

Bisphosphonates for osteoporosis treatment in women

Low-dose MDCT of the abdomen and pelvis reduces hospital stay in patients with acute nonspecific abdominal pain

FluMist may help reduce the burden of seasonal influenza

Extremely low-dose MDCT useful for reducing hospital stay for patients with acute abdominal pain

Adalimumab shows potential for Crohn's disease

Virtual colonoscopy most cost-effective colon cancer screening test

Discovery of important clue to the susceptibility of individuals to Crohn's disease

Schering-Plough announces ZETIA spproved in Japan

Researchers identify key gene that may be a marker of breast cancer metastasis

Researchers find hepatitis A and hepatitis C attack same protein to block immune defenses

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News